At the completion of this educational session, learners will:
- Understand epidemiologic data comparing cardiovascular disease risk in populations with and without HIV.
- Appreciate immune-mediated mechanisms of heightened cardiovascular disease risk in HIV, which have been elucidated through clinical physiology studies.
- Recognize, in clinical practice, cardiovascular disease risk factors in HIV-infected patients.
- Be aware of potential future immune-modulatory therapeutic strategies to mitigate cardiovascular disease risk in HIV.
Markella Zanni went to Harvard Medical School, completed her internal medicine residency and chief residency at Brigham and Women’s Hospital, followed by an endocrinology fellowship at Massachusetts General Hospital, and then joined the MGH Faculty. Her main research interest is in immune-mediated mechanisms of cardiovascular disease risk in HIV. She has lead-authored and contributed to important papers on atherosclerotic plaque vulnerability and inflammation among HIV-infected patients in such journals as AIDS and JAMA. Dr. Zanni’s research has been recognized with a KL2 MeRIT award from the Harvard Catalyst and with a Claflin Distinguished Scholar award from MGH.
To obtain CME credit for this and other PRN programs, please visit the PRN Video Channel
at the Clinical Education Initiative (CEI) web site http://www.ceitraining.org/prn-video/. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.